



It has been a year since Covid-19 (coronavirus disease of 2019) or severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) fi rstly reported in Wuhan, China.1 This infection indiscriminately affect from 
neonate until the elderly, and pregnant women also inevitable. Since March 2020, WHO has already 
declared this situation as a pandemic.2 Covid-19 contagion can transmit into two methods,  close contact 
from infected people, the droplet dispersion into the mouth, eye, nose, or airway tract until the alveoli, 
touch from a specifi c object that contains the virus then the person sweep the mouth, nose or the eye.3 
The virus is single-stranded RNA with 4 structural proteins, S (spike), E (envelope), N (nucleocapsid), 
and M (membrane). A crucial point in the pathogenesis is the binding between S protein to the ACE 2 
receptor in the pneumocyte at alveoli. Subsequently, endocytosis happens and virus RNA is released 
and replication takes place inside the cell. Eventually, the new virus will be released and it will infect 
another cell. And it will provoke some immunologic reaction inside alveoli and in blood circulation.4
Then, how about in pregnant women? The maternal immune system more susceptible to Covid-19 
infection due to in these conditions undergo decrease of lymphocyte, NGK2A inhibitor receptor, and 
increase of ACE2, IL-9, IL-10, and IP-10 receptors.5 Like another maternal infection, the fi rst thing in 
mind is there any vertical transmission to the fetus? The scientifi c report already stated that vertical 
transmission to the fetus is low, around 3.2% in third-trimester mother with Covid-19 infection, without 
an adverse event to the neonate.6 Beside of ACE2 receptor in the placenta, N and S proteins is highly 
expressed in the placenta in confi rmed case mother.7 Thus far, Covid-19 infection does not correlate 
with the neonatal poor outcome but somehow isolates the mother from the baby have an important 
role to cut off the transmission.8 However, Covid-19 is related to an increased risk of preterm labor 
and fetal distress.9 It is still controversy in the delivery method with Covid-19 infection. Until now, no 
recommendation for the best method for delivery concerning better outcome for the mother and 
also prevention vertical transmission. The delivery method selection should consider the availability 
of health care providers, hospital facility, spatial room of care, procurement of personal protective 
equipment (PPE), ability to implement, human resources, and exposure risk of infection. It will infl uence 
the physician who took care of the patient, to determine the suitable method of delivery for each 
patient. Rooming-in can be performed in Covid-19, the transmission risk to the baby is low, and no 
risk discrepancy SARS-CoV-2 infection in rooming-in baby and not rooming-in.10 No evidence that the 
virus is discovered in the breastmilk. Breastmilk gives important nutrition for the baby. Nevertheless, 
in this pandemic era, the Indonesian Pediatric Association recommends a discussion and decision in 
conjunction with healthcare, mother, and family.  The recommendation contraception in mother after 
delivery is long-acting reversible contraceptive (LARC) method and can be given right after delivery 
like intrauterine device or implant. In the patient with Covid-19 with hormonal contraception, some of 
these drugs have such drug interactions. It will affect the favipiravir clearance, baricitinib and sarilumab 
will decrease the level and activity of hormonal contraception, while lopinavir/ritonavir will increase 
hormonal contraception in blood. No data regarding in concomitant with remdesivir use. Meanwhile, 
tocilizumab has no interaction with hormonal contraception.11 Another issue is regarding maternal 
vaccination. Some pharmaceutical companies have already performed research on the Covid-19 vaccine. 
So far, just one vaccine has been published phase 3 trial from BNT162b2 mRNA with protection claim 
until 95%.12 Unfortunately, this study has not proven the effi cacy in pregnant women. The vaccination 
program in pregnant women is not only to give protection or prevention to the mother but also to 
prevent congenital infection and neonatal infection.13 It is very interesting to await in the future months, 
whether the vaccine can protect not only the general adult population but also pregnant women and 
the neonate.
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